Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Cipla Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500087
ISIN Demat	INE059A01026
Book Value	419.19

NSE Code	CIPLA
Dividend Yield %	1.21
Market Cap	1072048.72

P/E	30.50
EPS	43.52
Face Value	2


	BSE		NSE

13-May-2026

Last Price	1327.15
Net Change	35.15
% Change	2.72%
Prev.Close	1292.00
Open	1279.95
High	1355.95
Low	1275.00
Volume	327365

Last Price	1327.60
Net Change	35.3
% Change	2.73%
Prev.Close	1292.30
Open	1279.10
High	1356.60
Low	1274.70
Volume	6015153

Value	433914543
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1355.95
52-Week High	1672.20
52-Week Low	1165.55

Value	7947423229.4
Best Buy	1327.60
Best Sell	0.00
Best Quantity	193
Sell Quantity	0
Today's Range	1356.60
52-Week High	1673.00
52-Week Low	1165.70

Open Price	1272.30
High Price	1361.80
Low Price	1272.30
Last Price	1332.90
Prev Close	1293.80
Change	39.10
% Change	3.02 %

Average Price	1318.79
Underlying Value	1327.60
Number of contracts traded	31503
Turnover in Rs. Lakhs	155797
Open Interest	14103380.00
Change in O I	319130.00
% Change in O I	2.32 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	193
Price	1327.60

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	7125
Price	1333.6

Quantity	1125
Price	1336.7

Holding Details

Latest Corporate Events

Bonus

3 : 2

24-Apr-06

Book Closure

11-Aug-21

25-Aug-21

Dividend

150 %

27-Jun-25

Company News

13-05-2026

Cipla’s consolidated net ...

13-05-2026

Cipla informs about inves...

23-04-2026

Cipla’s arm gets USFDA’s ...

23-04-2026

Cipla informs about discl...

23-04-2026

Cipla shines as its arm g...

18-04-2026

USFDA concludes inspectio...

20-03-2026

Cipla surges on getting n...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.